NIFTY
17.10  0.15%
 11743.25
S&P BSE SENSEX
59.79  0.15%
 39114.47
Sun Pharmaceutical Industries Ltd.
NSE : SUNPHARMA BSE : 524715 ISIN code : INE044A01036
on 25-Apr-2019 09:54
NSE
3.65    0.78%
Rs. 473.00
 
Days Low
Rs. 466.3
Days High
Rs. 474.65

Open Rs. 468.9
 
52 week Low
Rs. 375.4
52 week High
Rs.678.8
 
 
Bid :                 474.25 (89)
Offer :        474.55 (59)
BSE
Rs.474.10
4.95    1.06%
on 25-Apr-2019 10:08
BSE
4.95    1.06%
Rs. 474.10
 
Days Low
Rs. 465.25
Days High
Rs. 474

Open Rs. 465.25
 
52 week Low
Rs. 370.2
52 week High
Rs.679.3
 
 
Bid :                 474.25 (89)
Offer :        474.55 (59)
NSE
Rs.473.00
3.65    0.78%
 
 
Last Price (Rs.)  474.10 Value  31640011.70
Net Change (Rs.)  4.95 Best Buy  474.25
Volume  66737 Best Sell  474.55
Prev.Close (Rs.)  469.15 Best Quantity  89
Open (Rs.)  468.90 Sell Quantity  59
High (Rs.)  474.65 52-Week High (Rs.)  678.80
Low (Rs.)  466.30 52-Week Low (Rs.)  375.40
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  1133805.74
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Currents Investments447.60 400.10 735.60 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Dr. Reddys Lab 2883.85 478909 749.81 84.45 0.69
Piramal Enterprises 2563.55 474289 1088.53 89.12 0.98
Aurobindo Pharma 798.45 467824 188.62 25.80 0.31
Divis Lab 1735.50 460721 251.75 52.98 0.58
Cipla 563.25 453812 186.99 30.88 0.53
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2018Sep 2018Jun 2018
Net Sales22612.6022992.5026075.20
Operating Profit2023.705926.105375.80
PBDT689.90-7731.504007.90
Net Profit-386.80-9064.202593.90
More> 
 
Company News
4/20/2019 12:00:00 AM
Sun Pharmaceutical Industries submits shareholding pattern
4/11/2019 12:00:00 AM
Sun Pharmaceutical Industries informs about disclosure
4/11/2019 12:00:00 AM
Pratham Investments informs about disclosure
More>
 
Ratios
   Earnings Per Share (Rs)-2.06 
   Book NAV/Share(Rs)82.40 
   PAT Margin (%)-6.22 
   Asset Turnover(x)0.23 
   PER(x)0.00 
   Yield(%)0.40 
   EV/Core EBITDA(x)100.39 
   M Cap / Sales15.00 
   Net Sales Growth(%)3.12 
   PAT Growth(%)-2065.46 
   Total Debt/Equity(x)0.35 
   Current Ratio(x)0.56 
   Quick Ratio(x)0.39 
   Total Debt/Mcap(x)0.06 
More>